rendering of a globe and news stories

In the News

BioPharm International (February 2019)

Understanding Leaching from Stoppers into Lyophilized Drugs

Steven Zdravkovic examines options for extractable and leachable studies to evaluate leaching from primary packaging into lyophilized drugs.

BioPharm International
Outsourcing-Pharma (February 2019)

PPD signs exclusive agreement with China-based AI company

Niklas Morton explains how the new collaboration will help pharma companies create better optimized protocols that will prove to be more attractive to sites and investigators because they are tailored to their patient population.

Outsourcing-Pharma
FierceBiotech (February 2019)

PPD inks deal with China’s HLT to create data science-driven research solutions

The partnership will focus on data-driven feasibility, patient recruitment and real-world evidence offerings for both global and China-based pharma and biotech companies.

fierce biotech logo
Regulatory Rapporteur (January 2019)

Regulatory reforms in Australia – Improving access to new medicines

Peter Lynch discusses regulatory changes in Australia that are designed to lead to earlier access to lifesaving medicines for patients.

regulatory rapporteur logo
Regulatory Focus (January 2019)

Proactive regulatory intelligence communication

Kirsten Messmer outlines regulatory intelligence communication approaches for medium to large companies and highlights the advantages and disadvantages of each.

regulatory focus logo
BioProcess International (December 2018)

PPD beefing up biologics lab services in Ireland

PPD expanding its biologics capabilities in Athlone to include cell and gene therapy analytical testing.

bioprocess logo
Contract Pharma (December 2018)

PPD Expands GMP Lab Testing Capabilities

PPD Laboratories is focused on providing cutting-edge gene and cell therapy analytical testing services and capabilities around the world.

Contract Pharma
Outsourcing-Pharma (December 2018)

PPD adds biologics testing to GMP lineup in Ireland

The company’s goal is to offer the same extensive biologic, gene and cell therapy portfolio to clients in both Europe and North America.

Outsourcing-Pharma
American Pharmaceutical Review (December 2018)

Osteoporosis: Addressing the unmet need

Rose Blackburne and Davide Garrisi provide an overview of the osteoporosis landscape and the associated regulatory environment.

American pharmaceutical review logo